chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day I received the 2nd SHINGRIX vaccine, I experienced tiredness, severe headache, fever that lasted a day and a half. The left arm where the shot was taken, started to get swollen and itchy 3 days after. 5 days after the vaccine, my body broke out with chickenpox like rashes, covering about 70-80% of the body. They are very itchy. At the moment a day since the rashes broke out, there is no blister, and no burning or tingling feeling on the skin yet.
There was a COIVD-19 vaccine given incorrectly. The pt had no side affects or health complaints.
petechiae (5days after 2. vaccine); Prev dose administration date: 18Apr2021/ dose 2 administration date:02May2021; Fainting-like spells very 2-10mins for 3 hours - 13mins after 2. vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02May2021 at 08:30 as dose 2, single (Lot number: EW0162) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "low blood pressure" (unspecified if ongoing); "migraines" (unspecified if ongoing), notes: migraines (25+years); "endometriosis" (unspecified if ongoing); "meningioma" (unspecified if ongoing), notes: meningioma in left cavernous sinus. Concomitant medication(s) included: LEVONORGESTREL. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW0172, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 18Apr2021, when the patient was 38-year-old, for COVID-19 immunization, reaction(s): "Suspected vestibular migraine", "Fainting", "overactive stress response and sensory overload, sensitivity to light, sound, temperature change and smell causing dizziness", "electrical flash in brain after watching TV", "dizziness when reading on mobile and scrolling or switching windows on computer; dizziness when reading glossy pages", "erratic blood pressure: increased blood pressure by 20-30 points during most part of a day or too low when tired or after meals (85/55)", "increased heart rate", "heart palpitations", "increased body temperature by 1-2 degrees", "dermatitis-like rash", "dermatitis-like rash". The following information was reported: SYNCOPE (disability, medically significant) with onset 02May2021, outcome "not recovered", described as "Fainting-like spells very 2-10mins for 3 hours - 13mins after 2. vaccine"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 02May2021, outcome "unknown", described as "Prev dose administration date: 18Apr2021/ dose 2 administration date:02May2021"; PETECHIAE (disability) with onset 07May2021, outcome "not recovered", described as "petechiae (5days after 2. vaccine)". The events "fainting-like spells very 2-10mins for 3 hours - 13mins after 2. vaccine", "petechiae (5days after 2. vaccine)" and "prev dose administration date: 18apr2021/ dose 2 administration date:02may2021" required physician office visit. Therapeutic measures were taken as a result of syncope, petechiae.  Clinical course: No other vaccine in four weeks. Treatment Meclizine, B2 vitamin. No covid prior vaccination. No Covid tested post vaccination.  Follow-up attempts are completed. No further information is expected.
c/o not feeling well, sneezing, progressed to headache following day sore throat, muscle achiness, day 4 sore throat continues, runny nose, hoarseness, day five nearly completely hoarse continues to c/o not feeling well, low grade fever. First time receiving any flu vaccine. Reluctant to receive 2nd recommended vaccine in one month. Given OTC pain reliever.
Next night had menstruation early by 5 days and had lots of blood clots with a heavier period.
felt badly; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt badly) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Crohn's disease.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (felt badly). At the time of the report, MALAISE (felt badly) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported using medications for Crohn's Disease concomitantly. She mentioned that she cut back on her medicine and started feeling better. She feels it was her other medication causing her to feel badly. No treatment information was provided.   Reporter did not allow further contact
This case was reported by a physician via sales rep and described the occurrence of herpes zoster in a 60-year-old female patient who received SHINGRIX (batch number 4Y5KD, expiry date unknown) for prophylaxis. On 30th January 2019, the patient received SHINGRIX. In February 2019, 2 days after receiving SHINGRIX, the patient experienced herpes zoster and eruption. On an unknown date, the outcome of the herpes zoster and eruption were unknown. It was unknown if the reporter considered the herpes zoster and eruption to be related to SHINGRIX. Additional details were provided as follows: The patient experienced herpes zoster without complication. There were 3 distinct areas of eruption on left anterior arm. Rash presented 2 days after vaccine was administered.
Runny Nose , Fluid in the head, excessive saliva , Left Eye Runny starting 10/26/21, husband and daughter recently tested positive
developed pain along with erythematous papules and vesicles on left side of face from temple to her mouth. There were crusting blisters around her mouth. She also developed headache.  She was treated for shingles with Valacyclovir  and Ibuprofen and is improving.
On 1/19/2023, my husband and daughter tested positive for COVID-19. We then isolated from each other and wore masks. On 1/20/2023, I developed a sore throat, head congestion, and runny nose. That evening, I underwent a PCR test; on 1/21/2023, I learned that the result was positive. I continued symptomatic care on 1/21/2023 and 1/22/2023; I took fluids and MUCINEX FAST MAX all-in-one cold & flu (daytime version during the day, nighttime version at night). On 1/23/2023, my symptoms worsened. I developed chest pain, difficulty breathing, a chest cough, and lethargy. On 1/24/2023, I had a telehealth visit with my asthma specialist, who prescribed me albuterol nebulizer treatment, budesonide nebulizer treatments, and ipratropium bromide nasal spray. I also continued the aforementioned MUCINEX medicines. I took all of these medications until 1/27/2023. On the night of 1/26/2023, I had difficulty breathing, and my cough was so severe and disruptive that I called my doctor on the morning of 1/27/2023. They prescribed me a five-day course of prednisone. I continued to use the previously mentioned prescription and OTC medicines and added the prednisone to the regimen. My symptoms began improving on 1/28/2023 and continued to decrease in severity during the remaining four days I was on the prednisone. My chest tightness, pain, and cough improved during this period. I began to decrease the frequency at which I took the albuterol and budesonide nebulizer treatments on 2/1/2023. On 2/3/2023, I had stopped taking all of the medications and I went in for an in-person follow-up with my asthma specialist. The follow-up went very well, and my specialist had me take FLOVENT for the next month. If I felt well at the end of the month, I could taper the frequency of FLOVENT treatments during March 2023. My symptoms did improve during this period, and I stopped taking FLOVENT during the middle of March 2023. After that, my only lingering symptom, which I still have today, a very short burst of nonproductive coughing whenever it's cold outside or when I do mild exercise (e.g. climbing the stairs, running from room to the next). However, it's not disruptive.
Soreness at point of injection, beginning a few hours after shot.  Greater swelling/discomfort at approximately 4AM the next morning.  Mild fatigue, slight headache, mild swelling at lymph nodes approximately 20 hours after dose.
Sent home from school with probable chicken pox. Grandmother presented child to BCHD for confirmation. Agreed likely chicken pox, schools reporting mutiple cases. Refered to Dr or NP for proper diagnosing and treatment if any.
Have had a stable meningioma for almost 9 years.   Recent MRI scan on 4/30 showed growth.     When I received vaccine survey, I noted I had been to the doctor for this.
8 hours after IM injection of pneumovax, severe pain, swelling at site of injection. Requiring Vicodin, Benadryl, cold packs and rest. Symptoms abated after 72 hours.  Follow up on 10/14/04 states: "Per telephone follow up with MD reporter, the pt was temporarily disabled for 3 days due to her adverse events. There was NO permanent disability. She was treated and fully recovered. Required emergency room/doctor visit."
Body aches, nausea, severe vomiting, stomach pain, fever, extreme fatigue
Seven days post vaccination child woke up complaining of a sore neck. Mom stated she thought child had an ear infection so she gave the child Motrin for the pain and mild fever. She also stated that after a few hours the child's neck appeared swollen on one side and there was a slight rash on the front of her neck. Mom also stated that she took the child to the doctors' office that morning and the doctor diagnosed the child as having mumps. Mom stated that the child was fine in three days. Mom told the nurse at the clinic where the vaccine was given on 5/20/04 about this reaction while she was receiving vaccines for her son.
about 4 or 5Pm child eyes, throat, tongue & lips were swollen, red spots in stomach, forehead & eyes;welts all over body & breathing difficulty;recv DPH & breathing tx;
This spontaneous report was received from an administrator referring to multiple unknown patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II which had lot # L032182 and expiry date: 25-AUG-2017, (dosing details not provided). The vaccine was exposed to temperature of 45.5 degree Fahrenheit for 3 hours 30 minutes. The vaccine had no previous temperature excursion. The call was because of data logger. No adverse effects and no product quality complaint (PQC) reported. No further information provided. This is one of the three reports received from the same reporter. Additional information has been requested.
patient developed shingles on 3/20/2021 and ultimately a flare of her polymyositis
Break through case of covid 19.  Severe sore throat, severe chills, malaise, fatigue,  mild coughing.  Felt fine going to bed at 10PM on 12/25 but awoke at 2AM on 12/26 with severe chills and sore throat with difficulty swallowing.  Mild cough.  Home test kit for covid positive morning of 12/26.    Symptoms continued and worsened over 12/26 and 12/27.   Never short of breath.  Oxygen sats mostly above 96%.    Obtained PCR confirmation testing on morning of 12/27--positive for covid.  Arranged monoclonal infusion for 4pm on 12/27 (sotrovimab).  Dramatic symptomatic improvement with monoclonal infusion.  Felt partial improvement by 6-8 hours and by 15 hours felt 80% back to normal.  By 12/29 felt completely recovered.  I isolated myself from the rest of household as soon as my home kit was positive.  5 other household members were in the house and none got sick and all stayed negative on testing (home kits and PCR).
Normal labor and delivery. Birth weight 8 lb 11.3 oz. Hospital admission within 6 weeks of receiving the COVID vaccine.
Swollen split tongue, blisters in mouth, inflamed bleeding gums, swollen chapped lips, cannot taste food, all food tastes greasy. On 12/31 broke out with rash all over body, dry and itchy. Acyclovir 400mg/pilocarpine HCL 5mg/nystatin 100000unit/ml susp. I have seen my doctor 2x.  My mouth is still dry and gums are very tender..still bleeding.  My lips are still swollen and chapped.. some days worse than others, but never normal. Bumps or rash on arms, hands, legs, and back and neck.
Felt icky for first 2 days. Fever of 100.3; next 2 days. Chills, intestinal  distress, headache, nausea, vomit (small amount), not eating, dizzy and vertigo; 5th day. 99.7 fever, some appetite, intestinal distress and no stool for 3 days.
the patient received his first dose of GARDASIL, experienced a reaction two weeks later; received his second dose, and experienced another event shortly after that; This spontaneous report was received from the patient's father and refers to a currently 22 years old male patient. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.         On an unknown date, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) for prophylaxis(dosage schedule, route, anatomical location, lot number and expiration date were not reported), and experienced a reaction two weeks later (adverse event).         And on an unspecified date, the patient received the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) for prophylaxis(dosage schedule, route, anatomical location, lot number and expiration date were not reported), and experienced another event shortly after that (adverse event).      The outcome of adverse event was unknown.  At the time of the report, the causality between the aforementioned events and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) was not provided.
Dysphonia; Cough returned; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (Dysphonia), COUGH (Cough returned) and FATIGUE (Fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product LENVATINIB MESILATE (LENVIMA) for Endometrial cancer.    Concurrent medical conditions included Endometrial cancer. Concomitant products included PEMBROLIZUMAB (KEYTRUDA) for Endometrial cancer.   On 20-Apr-2021, the patient started LENVATINIB MESILATE (LENVIMA) (Oral) 20 mg once a day. On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced COUGH (Cough returned) and FATIGUE (Fatigue). On an unknown date, the patient experienced DYSPHONIA (Dysphonia). At the time of the report, DYSPHONIA (Dysphonia), COUGH (Cough returned) and FATIGUE (Fatigue) had not resolved.            No treatment information was provided.  Patient reports cough returned approximately 3 days ago after second Moderna injection Apr/24/2021. Patient has more fatigue and lethargy after injection. Patient did not feel any different with increase dose of Lenvima until taking the second COVID vaccine. Patient reports dysphonia since start of therapy possibly increased with increase dose of Lenvima. Labs completed this morning, will have Keytruda infusion today and MD appointment.   Reporter did not allow further contact
The morning after receiving the shot, I woke up at roughly 9am with a High fever (100+), headache, and general felt very sick.  Upon getting up and going to the bathroom, I fainted which peeing (standing up).  Upon waking up on the floor of the bathroom, I got up, was light headed, took 4 steps to the bathroom door, and fainted a second time.  Upon waking up the second time, I made it to bed and fell back asleep until 11:30.   I took my temperature at 11:30 and found it was 99.9 degrees.  I was feeling cooler (less fevered) then I had been at the time of the fainting incident.  I called a nurse through my insurance company, who instructed me to go to the ER.  I waited 3 hours in the ER waiting room, and then received Fluids, A CT head scan, an ECG 12 lead, and blood work.  All normal.  I felt better, if banged up, by the time I left the ER.   I hit my head and Left shoulder in the fall.
Reported ringing/popping in ears and not feeling well; reached parking lot and reported still not feeling well but couldn't describe how feeling. He reported nausea and fuzzy vision. Ended up fainting in parking lot of doctors clinic.
Developed 5in. diameter redness and swelling where shot was given, very sore. No fever or other S/S illness. Resolved after 2-3 days.
This spontaneous report as received from a physician refers to a 17 year old male patient. The patient was vaccinated with the first dose of GARDASIL (lot number, dose, route and injection site were not reported) on 27-SEP-2012. No other co-suspects were reported. No concomitant medications were reported. On 17-OCT-2012 the patient got his second dose. No adverse reaction reported. The reporter was connected with the support line for assistance. Additional information has been requested.
Dizziness, Headache, NauseaVomiting, sore arm Narrative:
RIGHT SIDE SWELLING BY RIB CAGE; Protocol: 21-0012: A Phase 1 2 Study of Delayed Heterologous SARS CoV 2 Vaccine Dosing Boost After Receipt of EUA Vaccines.  Manufacturer Receipt Date: 07-OCT-2021  A clinical investigator reported that a patient of unspecified age and sex (subject number and site number were not reported) experienced grade 1 right side swelling by rib cage (PT: swelling). The event occurred unknown days after COVID-19 vaccine  Ad26.COV2.S was administered intramuscularly for prevention of symptomatic SARS-CoV-2 virus infection. The action taken with study vaccine was not applicable. The outcome was recovering.  The subject's height, and weight were not reported. No past medical history or concurrent conditions were reported. No concomitant medications were reported.  On an unknown date, the subject was treated with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported.   On 20-JUL-2021, the subject experienced right side swelling by rib cage.   The outcome of erythema was recovering.  Investigator's causality assessment:  The event of swelling was not related to the study vaccine.  Company causality assessment: The event of swelling was not related to the study vaccine.
pt recvd vax 28FEB95;pt cried (but not too much) appeared pale while being held by parent;approx 5mins later, pulse 98, BP 68/40;examined by MD 10mins p/vax sl pale;otherwise nl;MD ? vaso-vagal episode
Onset about 6:00 pm on day of vaccination - arm very sore; temp >102 deg, Nausea, sever HA, arthralgias, stiff neck - on 6/21/07 left deltoid area very hot, red, tender, pain with abduction to 10deg forward to 20deg pt. reports arthralgias - continues at this time. Fever and chills 6/19 pm, 6/20 day - unable to move arm at all 20 to pain 6/19 pm and 6/20, (arm ok after 7 d.)
diarrhea; muscle aches; sweating and shaking from fever; shaking; sweating; Severe 5 day headache; severe joint pain in hands and elbow; severe chills; This is a spontaneous report from a contactable 51-years-old non-pregnant female consumer reported for herself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EL0739), via an unspecified route of administration on 17Feb2021 at 14:00 as single dose in left arm for covid-19 immunization. The patient's medical history was not reported. Historical vaccine included bnt162b2 on 27Jan2021 for covid-19 immunization (administration time=04:00 PM, vaccine location=Left arm, dose number=1). Concomitant medications included levothyroxine sodium and amlodipine besilate. The patient took Codeine in the past and had allergies. On 18Feb2021 at 16:00, the patient had severe 5-day headache, severe joint pain in hands and elbow, severe chills, sweating and shaking from fever, diarrhea, and muscle aches. The patient's laboratory details included covid-19 virus test with negative results on 17Feb2021. The patient did not take any treatment for the events. The outcome of the event was not recovered.  Information on the lot batch number has been requested.
After receiving her vaccine, client stating she have tingling and numbness around her mouth.  Client states she feels better.  Client went home.
BP elevated; Light headedness 24 minutes post shot; This is a spontaneous report from a contactable nurse (patient). A 36-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El1284), via an unspecified route of administration on 11Jan2021 15:15 at a single dose on right arm for COVID-19 immunization. Medical history included hypothyroidism, systemic mastocytosis and allergies to sulfa. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior to vaccination. The patient previously took fexofenadine hcl (ALLEGRA) and experienced allergies. The patient was administered with first dose of bnt162b2 on 21Dec2020 15:30 on right arm for COVID-19 immunization (lot number: El0140). No other vaccines received in four weeks prior to COVID vaccination. On 11Jan2021 15:39, the patient experienced light headedness 24 minutes post shot and BP (blood pressure) was elevated at 15:45. Patient laid on floor for 15-20 minutes and 49 minutes after shot, she felt so what back to normal with normal BP. No treatment was received for the adverse events. The patient has not been tested for COVID post vaccination. Patient recovered from BP elevated on 11Jan2021 at 16:04, and from light headedness on an unspecified date.
a patient received an improperly stored dose of ROTATEQ on 09/12/2019. No adverse effect reported.; a patient received an improperly stored dose of ROTATEQ on 09/12/2019. No adverse effect reported.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 12-SEP-2019, the patient was vaccinated with and improperly storage rotavirus vaccine, live, oral, pentavalent (ROTATEQ), orally, for prophylaxis, lot# S005874 with expiration date of 31-OCT-2020.  No adverse effects were reported.   It was stated that the vaccines underwent a temperature excursion lowest temperature below 2 degrees Celsius (1.2 C) for 24 hours 36 minutes. No previous temperature excursion was reported The call was not because of a "data logger".  No further information was provided. There was no Product Quality Complaint (PQC) involved in this case.
I?ve been vaccinated 14 days ago and I believe I had some mild symptoms...  4 days ago I woke up with a headache that extend from my right eyebrow all the way down through my neck.. i had also gotten my period so I took two Panadols as I was not feeling well; but it didn?t really do the job the next day I Figured it was congestion so I took an Allegra and that actually helped. The next morning I felt much better but still off so I took another Allegra. Finally yesterday I didn?t feel anything abnormal, and didn?t take an Allegra. but then the news came out... I took one.
Pt developed Generalized hives all over his body and itching.  Hives continue to present time requiring Benadryl after receiving booster shot of Pfizer. First two vaccines were Moderna and were well tolerated